Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
False
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read
April 7, 2026
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
1 min read
April 6, 2026
A new review unpacks how GMP standards, evolving regulations, and emerging production technologies are reshaping monoclonal antibody manufacturing
3 min read
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
March 25, 2026
Fabrice Gritti spent a year immersed in the world of DNA physics to resurrect a long-abandoned technique to solve modern challenges in cell and gene therapy analysis
6 min read
March 25, 2026
Industry leaders unpack the manufacturing innovations driving the next generation of advanced medicines in our latest eBook
1 min read
March 24, 2026
Engineering payload selectivity for a better quality of life
9 min read
March 23, 2026
An integrated machine learning framework adapts culture conditions during long perfusion runs
2 min read
False
False
False